NVIV Annual Total Liabilities
$3.08 M
-$579.00 K-15.84%
31 December 2022
Summary:
As of February 5, 2025, NVIV annual total liabilities is $3.08 million, with the most recent change of -$579.00 thousand (-15.84%) on December 31, 2022. During the last 3 years, it has fallen by -$666.00 thousand (-17.80%).NVIV Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVIV Quarterly Total Liabilities
$666.00 K
-$1.09 M-62.09%
30 September 2023
Summary:
As of February 5, 2025, NVIV quarterly total liabilities is $666.00 thousand, with the most recent change of -$1.09 million (-62.09%) on September 30, 2023. Over the past year, it has dropped by -$2.59 million (-79.56%).NVIV Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVIV Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.8% | -79.6% |
| 3 y3 years | -17.8% | -75.4% |
| 5 y5 years | -21.8% | -77.8% |
NVIV Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -91.7% | -98.2% |
InVivo Therapeutics Holdings Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $666.00 K(-62.1%) |
| June 2023 | - | $1.76 M(-19.3%) |
| Mar 2023 | - | $2.18 M(-29.3%) |
| Dec 2022 | $3.08 M(-15.8%) | $3.08 M(-5.6%) |
| Sept 2022 | - | $3.26 M(+0.1%) |
| June 2022 | - | $3.26 M(+7.7%) |
| Mar 2022 | - | $3.02 M(-17.2%) |
| Dec 2021 | $3.65 M(+34.2%) | $3.65 M(+39.0%) |
| Sept 2021 | - | $2.63 M(+5.0%) |
| June 2021 | - | $2.50 M(+16.0%) |
| Mar 2021 | - | $2.16 M(-20.7%) |
| Dec 2020 | $2.72 M(-27.2%) | $2.72 M(+0.7%) |
| Sept 2020 | - | $2.71 M(-0.3%) |
| June 2020 | - | $2.71 M(-5.6%) |
| Mar 2020 | - | $2.87 M(-23.2%) |
| Dec 2019 | $3.74 M(+65.1%) | $3.74 M(+13.8%) |
| Sept 2019 | - | $3.29 M(+4.7%) |
| June 2019 | - | $3.14 M(-8.4%) |
| Mar 2019 | - | $3.43 M(+51.2%) |
| Dec 2018 | $2.27 M(-42.4%) | $2.27 M(-24.3%) |
| Sept 2018 | - | $2.99 M(-88.4%) |
| June 2018 | - | $25.77 M(+418.7%) |
| Mar 2018 | - | $4.97 M(+26.3%) |
| Dec 2017 | $3.94 M(-32.6%) | $3.94 M(-9.4%) |
| Sept 2017 | - | $4.34 M(-5.7%) |
| June 2017 | - | $4.61 M(-7.5%) |
| Mar 2017 | - | $4.98 M(-14.6%) |
| Dec 2016 | $5.83 M(+20.0%) | $5.83 M(-12.1%) |
| Sept 2016 | - | $6.64 M(+12.6%) |
| June 2016 | - | $5.90 M(-4.9%) |
| Mar 2016 | - | $6.20 M(+27.5%) |
| Dec 2015 | $4.86 M(-54.9%) | $4.86 M(-29.7%) |
| Sept 2015 | - | $6.92 M(-42.0%) |
| June 2015 | - | $11.94 M(-28.6%) |
| Mar 2015 | - | $16.72 M(+55.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $10.78 M(+156.2%) | $10.78 M(+60.0%) |
| Sept 2014 | - | $6.74 M(-30.6%) |
| June 2014 | - | $9.70 M(+146.6%) |
| Mar 2014 | - | $3.93 M(-6.5%) |
| Dec 2013 | $4.21 M(-77.1%) | $4.21 M(+3.8%) |
| Sept 2013 | - | $4.05 M(+16.5%) |
| June 2013 | - | $3.48 M(-87.7%) |
| Mar 2013 | - | $28.18 M(+53.4%) |
| Dec 2012 | $18.37 M(-50.2%) | $18.37 M(+41.3%) |
| Sept 2012 | - | $13.00 M(-47.4%) |
| June 2012 | - | $24.73 M(-17.3%) |
| Mar 2012 | - | $29.89 M(-18.9%) |
| Dec 2011 | $36.86 M(+228.2%) | $36.86 M(+609.6%) |
| Sept 2011 | - | $5.19 M(-47.5%) |
| June 2011 | - | $9.89 M(-10.1%) |
| Mar 2011 | - | $11.01 M(+5897.4%) |
| Dec 2010 | $11.23 M(>+9900.0%) | - |
| Sept 2010 | - | $183.50 K(+3.8%) |
| June 2010 | - | $176.80 K(+62.1%) |
| Mar 2010 | - | $109.10 K(+8.3%) |
| Mar 2010 | $109.10 K(+131.6%) | - |
| Dec 2009 | - | $100.70 K(+8.4%) |
| Sept 2009 | - | $92.90 K(+0.2%) |
| June 2009 | - | $92.70 K(+96.8%) |
| Mar 2009 | $47.10 K(+842.0%) | $47.10 K(+412.0%) |
| Dec 2008 | - | $9200.00(+46.0%) |
| Sept 2008 | - | $6300.00(-25.0%) |
| June 2008 | - | $8400.00(+68.0%) |
| Mar 2008 | $5000.00(+127.3%) | $5000.00(-23.1%) |
| Dec 2007 | - | $6500.00(>+9900.0%) |
| Sept 2007 | - | $0.00(-100.0%) |
| June 2007 | - | $3900.00(+77.3%) |
| Mar 2007 | $2200.00(-95.3%) | $2200.00(-57.7%) |
| Dec 2006 | - | $5200.00(-38.1%) |
| Sept 2006 | - | $8400.00(-82.1%) |
| Mar 2006 | $47.00 K | $47.00 K |
FAQ
- What is InVivo Therapeutics Holdings annual total liabilities?
- What is the all time high annual total liabilities for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings annual total liabilities year-on-year change?
- What is InVivo Therapeutics Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for InVivo Therapeutics Holdings?
- What is InVivo Therapeutics Holdings quarterly total liabilities year-on-year change?
What is InVivo Therapeutics Holdings annual total liabilities?
The current annual total liabilities of NVIV is $3.08 M
What is the all time high annual total liabilities for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high annual total liabilities is $36.86 M
What is InVivo Therapeutics Holdings annual total liabilities year-on-year change?
Over the past year, NVIV annual total liabilities has changed by -$579.00 K (-15.84%)
What is InVivo Therapeutics Holdings quarterly total liabilities?
The current quarterly total liabilities of NVIV is $666.00 K
What is the all time high quarterly total liabilities for InVivo Therapeutics Holdings?
InVivo Therapeutics Holdings all-time high quarterly total liabilities is $36.86 M
What is InVivo Therapeutics Holdings quarterly total liabilities year-on-year change?
Over the past year, NVIV quarterly total liabilities has changed by -$2.59 M (-79.56%)